Clarivate | Australia, Austria, Belgium, etc. | 6 Mar 2024
For 13 years, Clarivate™ has identified the organizations leading the world in technology research and innovation. As the pace of innovation…
COHAUSZ & FLORACK | European Union, Sweden | 20 Feb 2024
On 1 February 2024, the Patent and Market Court handed down its judgment concerning Bayer’s patent protecting a once-daily dosing regimen of…
Osborne Clarke | Belgium, European Union, France, etc. | 7 Feb 2024
Debate and controversy around cannabis and its derivatives are nothing new, with a wide array of legal frameworks and restrictions on its use in…
Clyde & Co LLP | Germany, Sweden | 13 Nov 2023
Electricity has played a vital role in transforming every facet of human life, and its potential in medical applications is no exception…
Clarivate | Australia, Belgium, Canada, etc. | 12 Oct 2023
In a world driven by rapid advancements in artificial intelligence (AI), the landscape of Intellectual Property (IP) law and practice is poised for a…
Panoramic
PRO
Editor:
Geoffrey Levitt
DLA Piper
Panoramic guide (formerly Getting the Deal Through) enabling side-by-side comparison of local insights, including into the regulatory framework; clinical practice; marketing authorisation; amending authorisations; recall; promotion; enforcement of advertising rules; pricing and reimbursement; off-label use and unlicensed products; sale and supply; and recent trends.